Cargando…
Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls
BACKGROUND: The best data on prognosis comes from population-based incident cohorts but few such cohorts exist for Parkinson's disease and atypical parkinsonism. METHODS: The PINE study is a prospective follow-up study of an incident cohort of people with degenerative or vascular parkinsonism a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110002/ https://www.ncbi.nlm.nih.gov/pubmed/27553511 http://dx.doi.org/10.1016/j.parkreldis.2016.08.010 |
_version_ | 1782467640736874496 |
---|---|
author | Fielding, S. Macleod, A.D. Counsell, C.E. |
author_facet | Fielding, S. Macleod, A.D. Counsell, C.E. |
author_sort | Fielding, S. |
collection | PubMed |
description | BACKGROUND: The best data on prognosis comes from population-based incident cohorts but few such cohorts exist for Parkinson's disease and atypical parkinsonism. METHODS: The PINE study is a prospective follow-up study of an incident cohort of people with degenerative or vascular parkinsonism and age-sex matched controls. Participants have annual follow-up from diagnosis until death with review of primary/secondary care records and linkage to the UK death register. Data are collected on survival, disability (dependency on others for activities of daily living) and institutionalization. Research criteria are used to guide the clinical diagnosis, which is updated annually. We compared all-cause mortality, disability and institutionalization in patients (subdivided by diagnosis) and controls, adjusted for important confounders. RESULTS: 323 incident parkinsonian patients (199 Parkinson's disease, 124 atypical parkinsonism, mean age at diagnosis 75yrs) and 262 controls (mean age 75yrs) had 1349 and 1334 person-years follow-up respectively (maximum follow-up 10 years). All outcomes were worse in parkinsonian patients than controls, especially in atypical parkinsonism (adjusted mortality hazards ratios Parkinson's disease 2.49, 95%CI 1.72–3.58, atypical parkinsonism, 6.85, 95%CI 4.78–9.81). Median survival times for Parkinson's disease and atypical parkinsonism were 7.8 and 2.7 years respectively but were very age-dependent. At three years the rates of death or dependency were controls 21%, Parkinson's disease 46%, atypical parkinsonism 96% whilst overall institutionalization rates were 5%, 15% and 55% respectively. CONCLUSION: The prognosis of Parkinson's disease and atypical parkinsonism in this unselected incident cohort was significantly worse than previously reported. This has important implications for patient management. |
format | Online Article Text |
id | pubmed-5110002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-51100022016-11-21 Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls Fielding, S. Macleod, A.D. Counsell, C.E. Parkinsonism Relat Disord Article BACKGROUND: The best data on prognosis comes from population-based incident cohorts but few such cohorts exist for Parkinson's disease and atypical parkinsonism. METHODS: The PINE study is a prospective follow-up study of an incident cohort of people with degenerative or vascular parkinsonism and age-sex matched controls. Participants have annual follow-up from diagnosis until death with review of primary/secondary care records and linkage to the UK death register. Data are collected on survival, disability (dependency on others for activities of daily living) and institutionalization. Research criteria are used to guide the clinical diagnosis, which is updated annually. We compared all-cause mortality, disability and institutionalization in patients (subdivided by diagnosis) and controls, adjusted for important confounders. RESULTS: 323 incident parkinsonian patients (199 Parkinson's disease, 124 atypical parkinsonism, mean age at diagnosis 75yrs) and 262 controls (mean age 75yrs) had 1349 and 1334 person-years follow-up respectively (maximum follow-up 10 years). All outcomes were worse in parkinsonian patients than controls, especially in atypical parkinsonism (adjusted mortality hazards ratios Parkinson's disease 2.49, 95%CI 1.72–3.58, atypical parkinsonism, 6.85, 95%CI 4.78–9.81). Median survival times for Parkinson's disease and atypical parkinsonism were 7.8 and 2.7 years respectively but were very age-dependent. At three years the rates of death or dependency were controls 21%, Parkinson's disease 46%, atypical parkinsonism 96% whilst overall institutionalization rates were 5%, 15% and 55% respectively. CONCLUSION: The prognosis of Parkinson's disease and atypical parkinsonism in this unselected incident cohort was significantly worse than previously reported. This has important implications for patient management. Elsevier Science 2016-11 /pmc/articles/PMC5110002/ /pubmed/27553511 http://dx.doi.org/10.1016/j.parkreldis.2016.08.010 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Fielding, S. Macleod, A.D. Counsell, C.E. Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls |
title | Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls |
title_full | Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls |
title_fullStr | Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls |
title_full_unstemmed | Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls |
title_short | Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls |
title_sort | medium-term prognosis of an incident cohort of parkinsonian patients compared to controls |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110002/ https://www.ncbi.nlm.nih.gov/pubmed/27553511 http://dx.doi.org/10.1016/j.parkreldis.2016.08.010 |
work_keys_str_mv | AT fieldings mediumtermprognosisofanincidentcohortofparkinsonianpatientscomparedtocontrols AT macleodad mediumtermprognosisofanincidentcohortofparkinsonianpatientscomparedtocontrols AT counsellce mediumtermprognosisofanincidentcohortofparkinsonianpatientscomparedtocontrols |